Skip to content

Clinical trial to estimate safety and efficacy of radiation ablation therapy using CyberHeart System for atrial fibrillation of cancer patient.

Clinical trial to estimate safety and efficacy of radiation ablation therapy using CyberHeart System for atrial fibrillation of cancer patient. - Clinical trial to estimate safety and efficacy of radiation ablation therapy for atrial fibrillation of cancer patient.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000031322
Enrollment
3
Registered
2018-02-16
Start date
2017-02-16
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atrial fibrillation of cancer patient

Interventions

Radiation ablation therepy

Sponsors

National Cancer Center Hospital, Japan.
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) Patient with cancer. 2) Patient who will not have cure treatment for cancer. 3) Atrial fibrillation diagnosed by EKG or Holter EKG. 4) Patient with atrial fibrillation which is not controlled by medication. 5) Two cardiologist judge catheter ablation is not applied. 6) Patient does not have medical history of surgey for atrial fibrillation such as Mase surgery. 7) Age: 20-84. 8) Writtend informed consent. 9) Serum creatinine value under 1.3 mg/dL. 10) Patient does not have second and third degree auriculoventricular block. 11) Patient does not have uncontrolled hyperthyroidism. 12) The size of left atrium estimated by transthoracic cardiac ultrasound is less than or equal to 55 mm. 13) The ejection fraction of left venricule estimated by transthoracic cardiac ultrasound is more than or equal to 35%.

Exclusion criteria

Exclusion criteria: 1) Acute myocardial infarction in 8 weeks before enrollment. 2) Other clinical trial entry 3) Pregnancy

Design outcomes

Primary

MeasureTime frame
Incidence and severity of the adverse events by radiation ablation therapy.

Secondary

MeasureTime frame
Control rate of atrial fibrillation in 6 months

Countries

Japan

Contacts

Public ContactKoji Inaba

National Cancer Center Hospital, Japan. Department of Radiation Oncology.

koinaba@ncc.go.jp03-3542-2511

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026